• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Novartis pulls the plug on UK-based cardiovascular study

cafead

Administrator
Staff member
  • cafead   Mar 22, 2023 at 09:22: PM
via Novartis is calling off a UK-based trial for Leqvio in the primary prevention of cardiovascular events in patients with high cholesterol, the company confirmed on Wednesday.

article source
 

<